NUCANA PLC-ADR
NCNA · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.10
- Today’s Low
- $1.05
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.10
- Previous Close
- $1.08
- Volume
- 31.43K
- Market Cap
- $4.74M
- P/E Ratio
- --
- EPS
- $0.00
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 3 LOCHSIDE WAY, EDINBURGH, UNITED KINGDOM, EH12 9DT
- Country
- GB
- Listing Date
- 2017-09-28
- Fiscal Year End
- December
- Shares Outstanding
- 20.8B
- CIK
- 0001709626
- Website
- www.nucana.com
NuCana plc, a clinical-stage biopharmaceutical company, is dedicated to the development of products for the treatment of cancer. The company is headquartered in Edinburgh, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$3.38M
2026-03-31
$4.41M
2025-12-31
$2.73M
2025-09-30
$779K
Net Income
2026-06-30
-$3.09M
2026-03-31
-$3.86M
2025-12-31
-$2.45M
2025-09-30
-$281K
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.99
2026-03-31
--
2025-12-31
--
2025-09-30
$-0.08
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$3.38M
2026-03-31
-$4.71M
2025-12-31
-$2.73M
2025-09-30
-$3.5M
Effective Tax Rate
2026-06-30
9.75%
2026-03-31
9.59%
2025-12-31
5.4%
2025-09-30
55.11%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $3.38M | $4.41M | $2.73M | $779K |
| Net Income | -$3.09M | -$3.86M | -$2.45M | -$281K |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.99 | -- | -- | $-0.08 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$3.38M | -$4.71M | -$2.73M | -$3.5M |
| Effective Tax Rate | 9.75% | 9.59% | 5.4% | 55.11% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.